At the end of the latest market close, ClearPoint Neuro Inc. (CLPT) was valued at $25.80. In that particular session, Stock kicked-off at the price of $25.45 while reaching the peak value of $25.90 and lowest value recorded on the day was $23.95. The stock current value is $24.00.
Recently in News on February 19, 2021, ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021. ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will release financial results for its 2020 fourth quarter and full year, which ended December 31, 2020, on Thursday, March 4, 2021, after the market close. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
ClearPoint Neuro Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $31.29 on 02/16/21, with the lowest value was $14.35 for the same time period, recorded on 01/04/21.
ClearPoint Neuro Inc. (CLPT) full year performance was 336.36%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ClearPoint Neuro Inc. shares are logging -23.30% during the 52-week period from high price, and 739.13% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.86 and $31.29.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1932422 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the ClearPoint Neuro Inc. (CLPT) recorded performance in the market was 51.04%, having the revenues showcasing 156.68% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 435.12M, as it employees total of 33 workers.
Analysts verdict on ClearPoint Neuro Inc. (CLPT)
During the last month, 0 analysts gave the ClearPoint Neuro Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 13.08, with a change in the price was noted +18.52. In a similar fashion, ClearPoint Neuro Inc. posted a movement of +337.96% for the period of last 100 days, recording 232,981 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CLPT is recording 178.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 177.00.
ClearPoint Neuro Inc. (CLPT): Technical Analysis
Raw Stochastic average of ClearPoint Neuro Inc. in the period of last 50 days is set at 66.59%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 40.20%. In the last 20 days, the company’s Stochastic %K was 56.46% and its Stochastic %D was recorded 70.17%.
Let’s take a glance in the erstwhile performances of ClearPoint Neuro Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 51.04%. Additionally, trading for the stock in the period of the last six months notably improved by 471.43%, alongside a boost of 336.36% for the period of the last 12 months. The shares increased approximately by -5.66% in the 7-day charts and went down by 22.26% in the period of the last 30 days. Common stock shares were driven by 156.68% during last recorded quarter.